Dr. William R Mulley, Australia
A randomised controlled trial of intravenous immunoglobulin (IVIg) compared with standard of care for the treatment of chronic active antibody mediated rejection (VIPAR)

Mr. Hector Tejeda, Netherlands
Tissue-resident memory T cells in human kidney transplants have alloreactive potential

Dr. Abhishek Vashisth, India
Graft function stabilisation in chronic AMR: Can Tocilizumab be an option

Ms. Shubhi Kamthan, India
Urinary cytokine and microparticles in antibody-mediated renal allograft rejection

Prof. Enver Akalin, United States
Not all transplant glomerulopathy related to chronic antibody-mediated rejection

Dr. Erol Demir, Turkey
Desensitization-Resistant Eplet-Specific HLA Antibodies

Dr. Karin Boer, Netherlands
Dynamic release of kidney-derived urinary extracellular vesicles: potential biomarkers for acute rejection in kidney transplantation